Anorectic

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/5383 (2006.01) A61K 31/235 (2006.01) A61K 31/40 (2006.01) A61K 31/426 (2006.01) A61K 31/50 (2006.01) A61K 31/70 (2006.01) A61P 3/04 (2006.01)

Patent

CA 2554455

The present invention relates to an anorectic containing a compound having a DGAT inhibitory activity (DGAT1 inhibitory activity) or a prodrug thereof or a pharmaceutically acceptable salt thereof as an active ingredient. The present invention provides an anti-obesity drug which is an anorectic that does not directly act on the central nervous system and is satisfactory in terms of activity, and a therapeutic strategy for preventing or treating obesity.

La présente invention concerne un anorexigène dont l'ingrédient actif est un composant ayant une action inhibitrice sur le gène DGAT (action inhibitrice sur le gène DGAT1), ou un promédicament dérivé ou un sel dérivé acceptable sur le plan pharmaceutique. La présente invention consiste en un médicament contre l'obésité qui est un anorexigène n~agissant pas directement sur le système nerveux central et qui est satisfaisant en termes d'activité, et en une stratégie thérapeutique de prévention de l~obésité.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anorectic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anorectic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anorectic will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1901405

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.